Skip NavigationSkip to Content

Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1

  1. Author:
    Briggs, C. J.
    Ott, D. E.
    Coren, L. V.
    Oroszlan, S.
    Tozser, J.
  2. Author Address

    Tozser J Debrecen Univ Med, Sch Med, Dept Biochem & Mol Biol POB 6 H-4012 Debrecen Hungary Debrecen Univ Med, Sch Med, Dept Biochem & Mol Biol H-4012 Debrecen Hungary ABL Basic Res Program, Mol Virol & Carcinogensis Lab Frederick, MD USA NCI, Frederick Canc Res & Dev Ctr, AIDS Vaccine Program, SAIC Frederick Frederick, MD USA
    1. Year: 1999
  1. Journal: Archives of Virology
    1. 144
    2. 11
    3. Pages: 2151-2160
  2. Type of Article: Article
  1. Abstract:

    The presence of FK506-binding protein-12 was demonstrated in virions of HIV-I, although its concentration was lower than that of cyclophilin A. The effect of two inhibitors of the peptidyl-prolyl cis-trans isomerases FK506 and cyclosporin A (CsA) was studied in H9 cells that were chronically infected by HIV-I. Both drugs inhibited virus production in the infected cells in a concentration-dependent manner, by decreasing the number of the producing cells. FK506 did not have an effect on Gag processing, based on the p24 antigen content of virions produced in the presence of this drug. Furthermore, FK506 treatment of uninfected H9 cells did not diminish their susceptibility toward HIV-1 infection, whereas CsA treatment decreased the degree of HIV-1 infection with an IC50 of 1-2 mu g/ml. Also, pretreatment of the virus with CsA decreased its infectivity in HeLaCD4-LTR/beta-gal cells; in contrast, at concentrations up to 10 mu g/ml, FK506 did not have an effect. Our findings on the antiviral activity of FK506 and CsA suggest that FK506 is effective only in chronically infected cells, by selectively inhibiting the growth of HIV-1 infected cells, whereas CsA has a specific effect on virus replication. [References: 25]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel